Table 8: Summary incremental cost-effectiveness ratios across selected studies evaluating SPECT.
Study | Comparator | Outcome of interest | Reported as cost-effective? | ICER |
---|---|---|---|---|
Sharples et al., 2007 | MRI | Cost per QALY | Yes | Dominant |
Bedetti et al., 2008 | Stress ECHO | Cost per correct diagnosis | No | Dominated |
Garber et al., 1999 | Stress ECHO | Cost per QALY | No | USD (1996) $78,444 |
Hayashino et al., 2004 | Stress ECHO | Cost per QALY | No | Dominated |
Hernandez et al., 2007 | Stress ECHO | Cost per QALY | No | Dominated |
Kuntz et al., 1999 | Stress ECHO | Cost per QALY | No | USD (1996) $62,800 |
Lee et al., 2002 | Stress ECHO | Cost per QALY | Yes | Not reported* |
Sharples et al., 2007 | Stress ECHO | Cost per QALY | Yes | Less costly, same QALYs |
Shaw et al., 2066 | Stress ECHO | Cost per LYS | No | USD (2003) $72,187 |
Abbreviation: ND = Not defined
SPECT was cost-effective when the probability of CAD was >=30%. Stress ECHO was cost-effective when the probability of CAD was <=20%.